Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review

Understanding the statistical analysis of resistance data

In: Antiretroviral Resistance in Clinical Practice. London: Mediscript; 2006. Chapter 15.
Free Books & Documents
Review

Understanding the statistical analysis of resistance data

Alessandro Cozzi-Lepri.
Free Books & Documents

Excerpt

Phenotypic resistance data are a continuous statistical variable that indicate the concentration of drug needed to inhibit the replication of a patient's virus. Typically, this is measured by specifying the concentration of drug needed to inhibit 50% or 90% of virus replication (IC50 or IC90, respectively), or by comparing the fold change in drug concentration required to inhibit the replication of the patient's virus compared with a sensitive virus isolate. In contrast, genotypic resistance data are typically a series of binary variables documenting the presence of specific mutations in the amino acid sequences of the HIV-1 genome in the reverse transcriptase (RT) or protease (PR) regions (e.g. yes/no variables for resistance mutations 41L, 65R, 67N and 184V). This chapter focuses on the statistical analysis of the genotypic resistance data that are generated from routine clinical care.

PubMed Disclaimer

References

    1. Adachi A, Gendelman HE, Koenig S et al. Production of acquired immunodeficiency syndrome-associated retrovirus in human and non-human cells transfected with an infectious molecular clone. J Virol. 1986;59:284–291. - PMC - PubMed
    1. Los Alamos National Laboratory HIV Databases. http://hiv-web.lanl.gov/content/index (accessed on 22 November 2005).
    1. Costagliola D, Cozzi-Lepri A, Dalban C, Chang B. on behalf of the Standardisation and Clinical Relevance of HIV Drug Resistance. Project from the Forum for Collaborative HIV Research. Antivir Ther. 2005;10:S11.
    1. HIV Resistance Response Database Initiative. http://www.hivrdi.org/ (accessed on 22 November 2005).
    1. Phillips AN, Dunn D, Sabin C. UK Collaborative Group on HIV Drug Resistance; UK CHIC Study Group et al. Long term probability of detection of HIV-1 drug resistance after starting antiretroviral therapy in routine clinical practice. AIDS. 2005;19:487–494. - PubMed

LinkOut - more resources